BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 27245142)

  • 1. Small Molecules Revealed in a Screen Targeting Epithelial Scattering Are Inhibitors of Microtubule Polymerization.
    Hoj TH; Robinson RJ; Burton JC; Densley-Ure RA; Olson TV; Williams LK; Coward L; Gorman G; Hansen MD
    J Biomol Screen; 2016 Aug; 21(7):671-9. PubMed ID: 27245142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms.
    Siddiqui-Jain A; Hoj JP; Hargiss JB; Hoj TH; Payne CJ; Ritchie CA; Herron SR; Quinn C; Schuler JT; Hansen MDH
    Bioorg Med Chem Lett; 2017 Sep; 27(17):3992-4000. PubMed ID: 28780159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular contractility changes are sufficient to drive epithelial scattering.
    Hoj JP; Davis JA; Fullmer KE; Morrell DJ; Saguibo NE; Schuler JT; Tuttle KJ; Hansen MD
    Exp Cell Res; 2014 Aug; 326(2):187-200. PubMed ID: 24780819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma membrane ion fluxes and NFAT-dependent gene transcription contribute to c-met-induced epithelial scattering.
    Langford PR; Keyes L; Hansen MD
    J Cell Sci; 2012 Sep; 125(Pt 17):4001-13. PubMed ID: 22685327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel small molecules that inhibit STAT3-dependent transcription and function.
    Kolosenko I; Yu Y; Busker S; Dyczynski M; Liu J; Haraldsson M; Palm Apergi C; Helleday T; Tamm KP; Page BDG; Grander D
    PLoS One; 2017; 12(6):e0178844. PubMed ID: 28636670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling.
    Owusu BY; Bansal N; Venukadasula PK; Ross LJ; Messick TE; Goel S; Galemmo RA; Klampfer L
    Oncotarget; 2016 May; 7(20):29492-506. PubMed ID: 27121052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Krüppel-like factor 4 is involved in cell scattering induced by hepatocyte growth factor.
    Lai JK; Wu HC; Shen YC; Hsieh HY; Yang SY; Chang CC
    J Cell Sci; 2012 Oct; 125(Pt 20):4853-64. PubMed ID: 22854048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
    Pasdar M; Li Z; Marreli M; Nguyen BT; Park M; Wong K
    Cell Growth Differ; 1997 Apr; 8(4):451-62. PubMed ID: 9101091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the hepatocyte growth factor/Met pathway in cancer.
    De Silva DM; Roy A; Kato T; Cecchi F; Lee YH; Matsumoto K; Bottaro DP
    Biochem Soc Trans; 2017 Aug; 45(4):855-870. PubMed ID: 28673936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HGF inhibitory peptide HGP-1 displays promising in vitro and in vivo efficacy for targeted cancer therapy.
    Chen L; Li C; Zhu Y
    Oncotarget; 2015 Oct; 6(30):30088-101. PubMed ID: 26254225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
    Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
    Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel spiroindoline targets cell cycle and migration via modulation of microtubule cytoskeleton.
    Kumar N; Hati S; Munshi P; Sen S; Sehrawat S; Singh S
    Mol Cell Biochem; 2017 May; 429(1-2):11-21. PubMed ID: 28213771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive enhancement of HGF-induced epithelial scattering by accessory growth factors.
    Chung JY; Davis JA; Price BD; Staley DM; Wagner MV; Warner SL; Bearss DJ; Hansen MD
    Exp Cell Res; 2011 Feb; 317(3):307-18. PubMed ID: 21075102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Small Molecule with Bridged Carbonyl and Tri-fluoro-aceto-phenone Groups Impedes Microtubule Dynamics and Subsequently Triggers Cancer Cell Apoptosis.
    Mohapatra S; Gupta V; Mondal P; Chatterjee S; Bhunia D; Ghosh S
    ChemMedChem; 2021 Sep; 16(17):2703-2714. PubMed ID: 33983670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium.
    Nusrat A; Parkos CA; Bacarra AE; Godowski PJ; Delp-Archer C; Rosen EM; Madara JL
    J Clin Invest; 1994 May; 93(5):2056-65. PubMed ID: 8182137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor.
    Gmyrek GA; Walburg M; Webb CP; Yu HM; You X; Vaughan ED; Vande Woude GF; Knudsen BS
    Am J Pathol; 2001 Aug; 159(2):579-90. PubMed ID: 11485916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics.
    Zheng S; Liu J; Wu Y; Huang TL; Wang G
    Future Med Chem; 2015; 7(18):2485-505. PubMed ID: 26670195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype-driven chemical screening in zebrafish for compounds that inhibit collective cell migration identifies multiple pathways potentially involved in metastatic invasion.
    Gallardo VE; Varshney GK; Lee M; Bupp S; Xu L; Shinn P; Crawford NP; Inglese J; Burgess SM
    Dis Model Mech; 2015 Jun; 8(6):565-76. PubMed ID: 25810455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.
    Accornero P; Miretti S; Starvaggi Cucuzza L; Martignani E; Baratta M
    J Mol Endocrinol; 2010 Feb; 44(2):115-25. PubMed ID: 19850646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents.
    Kim ND; Park ES; Kim YH; Moon SK; Lee SS; Ahn SK; Yu DY; No KT; Kim KH
    Bioorg Med Chem; 2010 Oct; 18(19):7092-100. PubMed ID: 20810285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.